MOTOR NEURON DISEASE
Clinical trials for MOTOR NEURON DISEASE explained in plain language.
Never miss a new study
Get alerted when new MOTOR NEURON DISEASE trials appear
Sign up with your email to follow new studies for MOTOR NEURON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
ALS drug trial halted before it even began
Disease control TerminatedThis study aimed to test an experimental drug called IC14 in 50 people with rapidly progressing ALS. Participants would have received either the drug or a placebo intravenously twice a week for 12 weeks. The goal was to measure changes in disease markers and track safety. However…
Matched conditions: MOTOR NEURON DISEASE
Phase: PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could a common alcoholism drug help slow ALS?
Disease control OngoingThis early-stage study tests a drug called acamprosate in 30 people with ALS who have a specific genetic change (C9orf72). The main goal is to see if the drug is safe and to check for any signs it might slow the disease. Participants take the pill three times a day for 24 weeks a…
Matched conditions: MOTOR NEURON DISEASE
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New headset lets ALS patients type with their brain
Knowledge-focused OngoingThis study is testing a new, comfortable headset that reads brain signals to help people with ALS communicate by typing on a virtual keyboard. The headset uses dry electrodes and is designed for daily use. Five people with ALS will try the device, and researchers will measure how…
Matched conditions: MOTOR NEURON DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC